Evidence map›Paper›PMID 35586410›Full record

ArticleFrontiers in psychiatry2022

Efficacy of the Therapeutic Game "Trisquel" in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study.

Adolfo Piñón-Blanco, Esperanza Vergara-Moragues, Olga Gutiérrez-Martínez, Patricia Fernández-Palleiro, Sonia Rodrigues, Daniela Rodrigues-Amorím, María Teresa Lage-López, Ana González-López, Teresa Velasquez, Mónica Amorim and 13 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 2 countries.

Adolfo Piñón-BlancoDrug Dependency Assistance Unit of Vigo City Council (CEDRO), Vigo, Spain.
Esperanza Vergara-MoraguesDepartamento de Psicobiología y Metodología en Ciencias del Comportamiento, Universidad Complutense de Madrid (UCM), Madrid, Spain.
Olga Gutiérrez-MartínezTranslational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Patricia Fernández-PalleiroTranslational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Sonia RodriguesDivision for the Intervention of Addictive Behaviors and Dependencies (DICAD) of the Regional Health Administration-North of Portugal, Porto, Portugal.
Daniela Rodrigues-AmorímPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, United States.
María Teresa Lage-LópezCitizens' Association for the Fight Against Drugs (Asociación Ciudadana de Lucha Contra la Droga), A Coruña, Spain.
Ana González-LópezCitizens' Association for the Fight Against Drugs (Asociación Ciudadana de Lucha Contra la Droga), A Coruña, Spain.
Teresa VelasquezComunidade Terapêutica Clínica do Outeiro, Porto, Portugal.
Mónica AmorimDivision for the Intervention of Addictive Behaviors and Dependencies (DICAD) of the Regional Health Administration-North of Portugal, Porto, Portugal.
Manuel Lloves-MoratinosCitizens' Association for the Fight Against Drugs (Asociación Ciudadana de Lucha Contra la Droga), ACLAD-Alborada, Vigo, Spain.
Isabel Viéitez-FernándezFerrol Association of Drug Addictions of Ferrol (ASFEDRO), Ferrol, Spain.
Gerardo Sabio-FernandezCitizens' Association for the Fight Against Drugs (Asociación Ciudadana de Lucha Contra la Droga), ACLAD-Alborada, Vigo, Spain.
Rebeca Graña-TorralbaFerrol Association of Drug Addictions of Ferrol (ASFEDRO), Ferrol, Spain.
Vanesa Vilar-DíazFerrol Association of Drug Addictions of Ferrol (ASFEDRO), Ferrol, Spain.
Indalecio Carrera-MachadoCitizens' Association for the Fight Against Drugs (Asociación Ciudadana de Lucha Contra la Droga), A Coruña, Spain.
Jesús Cancelo-MartinezCitizens' Association for the Fight Against Drugs (Asociación Ciudadana de Lucha Contra la Droga), ACLAD-Alborada, Vigo, Spain.
Adelino FerreiraDivision for the Intervention of Addictive Behaviors and Dependencies (DICAD) of the Regional Health Administration-North of Portugal, Porto, Portugal.
Susana CardosoDivision for the Intervention of Addictive Behaviors and Dependencies (DICAD) of the Regional Health Administration-North of Portugal, Porto, Portugal.
Tania Rivera-BaltanásTranslational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Francisco Otero-LamasDrug Dependency Assistance Unit of Vigo City Council (CEDRO), Vigo, Spain.
José Manuel OlivaresTranslational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Carlos SpuchTranslational Neuroscience Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Servicio Gallego de Salud · ESGalicia Sur Biomedical Foundation · ESCentro de Investigación Biomédica en Red de Salud Mental · ESMassachusetts Institute of Technology · USUniversidad Complutense de Madrid · ESUniversity Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Substance-related disorders (SRD) have been consistently associated with alterations both in cognitive and executive functions, which affect to patients' quality of life. The main objective of this work was to test the beneficial cognitive effects on patients with SRD after the implementation of "Trisquel," an intervention program in board game format. To check the effectiveness of Trisquel program, a group of people diagnosed with SRD was randomly assigned either to the experimental group or to the control group. The experimental group performed Trisquel structured sessions twice a week during 3 months, while the control group performed routinely conventional therapeutic activities with the same frequency and duration. Neuropsychological tests were done to both groups before and after the intervention. After the 3 months of intervention the experimental group showed the following statistically significant improvements for WAIS-III subtests: number key, symbol search, arithmetic, direct digits, inverse digits, total digits, letters-numbers in the processing speed index and in the working memory index. Regarding STROOP tests, statistically significant progress was observed in the phonetic fluency letter P, phonetic fluency letter M, phonetic fluency letter R subtests, word-reading and word-color subtests. The control group only obtained improvements for WAIS-III subtests of arithmetic, letters-numbers and in the working memory index. The results of this study confirm that "Trisquel" is an effective intervention program for people diagnosed with SRD, getting improvements in processing speed (psychomotor and reading), attentional subprocesses (focused and sustained) and executive functions (updating and inhibition).

Indexed as

cognitive impairmentneuropsychological rehabilitationpsychoeducationsubstance-related disordersTrisquel

Identifiers

PMID35586410
PMCPMC9108152
OpenAlexW4225268931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.